These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7059574)

  • 21. High-performance chromatofocusing and size-exclusion chromatography: separation of human uterine estrogen-binding proteins.
    Hutchens TW; Gibbons WE; Besch PK
    J Chromatogr; 1984 Aug; 297():283-99. PubMed ID: 6490762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Steroid receptor analyses of nine human breast cancer cell lines.
    Horwitz KB; Zava DT; Thilagar AK; Jensen EM; McGuire WL
    Cancer Res; 1978 Aug; 38(8):2434-7. PubMed ID: 667841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality control of estrogen and progesterone receptor assays.
    Chua D; Aw SE; Chan SH; Oon CJ
    Ann Acad Med Singap; 1986 Oct; 15(4):492-7. PubMed ID: 3566169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of sodium molybdate on molecular forms of steroid receptors in human breast tumors. The value of high performance liquid chromatography (HPLC)].
    Barbey P; Lechevrel C; Roussel G; Goussard J
    Bull Cancer; 1983; 70(4):253-65. PubMed ID: 6652244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Steroid receptors analysis in human mammary tumors by isoelectric focusing in agarose.
    Bailleul S; Gauduchon P; Malas JP; Lechevrel C; Roussel G; Goussard J
    Anal Biochem; 1988 Aug; 172(2):311-9. PubMed ID: 3189782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Separation of two molecular forms of human estrogen receptor by hydrophobic interaction chromatography. Gradient optimization and tissue comparison.
    Hyder SM; Wittliff JL
    J Chromatogr; 1989 Aug; 476():455-66. PubMed ID: 2777992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasminogen activator as a functional marker for estrogen dependence in human breast cancer cells.
    Yamashita J; Horiuchi S; Kimura M; Nishimura R; Akagi M
    Jpn J Cancer Res; 1986 Feb; 77(2):177-81. PubMed ID: 3082829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mechanism of action of the copper intrauterine device.
    Tamaya T; Nakata Y; Ohno Y; Nioka S; Furuta N
    Fertil Steril; 1976 Jul; 27(7):767-72. PubMed ID: 181276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrocautery: effects on steroid receptors in human breast cancer.
    Bloom ND; Johnson F; Pertshuck L; Fishman J
    J Surg Oncol; 1984 Jan; 25(1):21-4. PubMed ID: 6319822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sexual dimorphism characterizes steroid hormone modulation of rat aortic steroid hormone receptors.
    Lin AL; Shain SA
    Endocrinology; 1986 Jul; 119(1):296-302. PubMed ID: 3720665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality control of clinical steroid receptor assays in Sweden.
    Sällström JF; Björkqvist K
    Recent Results Cancer Res; 1984; 91():119-21. PubMed ID: 6729207
    [No Abstract]   [Full Text] [Related]  

  • 33. Molecular basis of endocrine-responsive cancers.
    Wittliff JL
    Clin Physiol Biochem; 1987; 5(3-4):160-78. PubMed ID: 3621797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Batch assay method evaluation of cytoplasmic estrogen receptor. Relative immunity of hydroxylapatite method from errors of measurement.
    Rosner AL; Teman GH; Bray CL; Burstein NA
    Eur J Cancer (1965); 1980 Nov; 16(11):1495-1502. PubMed ID: 7227424
    [No Abstract]   [Full Text] [Related]  

  • 35. Biological significance of cytoplasmic estrogen receptors.
    Lee SH
    Pathologica; 1987; 79(1059-1060):73-7. PubMed ID: 3441413
    [No Abstract]   [Full Text] [Related]  

  • 36. Progestin receptors from tissues either exhibiting or lacking estrogen response mechanisms. Comparison of conventional and high-performance liquid chromatography methodology.
    Hyder SM; Kohrs FP; Wittliff JL
    J Chromatogr; 1987 Jun; 397():269-78. PubMed ID: 3654820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of automated smoothing and deconvolution procedures for the determination of human breast cancer estrogen and progesterone receptor isoforms, after high-performance size-exclusion chromatography.
    Cren H; Lechevrel C; Roussel G; Lemoisson E; Goussard J
    J Chromatogr; 1993 May; 615(1):23-36. PubMed ID: 7688004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-performance size exclusion chromatography as a rapid method for the separation of steroid hormone receptors.
    Wiehle RD; Hofmann GE; Fuchs A; Wittliff JL
    J Chromatogr; 1984 Apr; 307(1):39-51. PubMed ID: 6725490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies.
    Elashry-Stowers D; Zava DT; Speers WC; Edwards DP
    Cancer Res; 1988 Nov; 48(22):6462-74. PubMed ID: 3180062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of cytoplasmic progesterone receptors in rat granulosa cells. Evidence for nuclear translocation.
    Naess O
    Acta Endocrinol (Copenh); 1981 Oct; 98(2):288-94. PubMed ID: 7293659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.